Pavadi Capital’s Dentsply Sirona XRAY Stock Holding History

Pavadi Capital’s Portfolio XRAY Stock Details XRAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-94,340	Closed	-$2.67M	–	27
2022 Q3	$2.67M	Sell	94,340 -9,094	-9%	-$311K	2.56%	22
2022 Q2	$3.7M	Buy	103,434 +16,468	+19%	+$666K	3.35%	17
2022 Q1	$4.28M	Sell	86,966 -8,048	-8%	-$425K	3.77%	14
2021 Q4	$5.3M	Buy	+95,014	New	+$5.23M	4.02%	14

Other funds holding XRAY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Nuance Investments Kansas City, Missouri $717M AUM 3.8% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Pavadi Capital's XRAY Position: Q4 2022 in Review

Pavadi Capital sold out of Dentsply Sirona (XRAY) in Q4 2022, closing a stake of 94,340 shares — an estimated $2.67M sold.

Pavadi Capital first reported a position in XRAY in Q4 2021 and held it in 4 quarters. The position peaked at $5.3M in Q4 2021. 436 funds tracked by Wall St. Rank hold XRAY as of Q4 2022.

Pavadi Capital reported no remaining Dentsply Sirona position as of Q4 2022 after selling out during the quarter.
Pavadi Capital sold 94,340 Dentsply Sirona shares in Q4 2022, an estimated $2.67M.
Pavadi Capital first reported a position in Dentsply Sirona in Q4 2021 and held it in 4 quarters.
Pavadi Capital's Dentsply Sirona position peaked at $5.3M in Q4 2021.
436 funds tracked by Wall St. Rank held Dentsply Sirona as of Q4 2022.

Based on Pavadi Capital's 13F filing for Q4 2022, filed 14 Feb 2023.